These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34825752)

  • 21. De novo pemphigus vulgaris and pemphigus foliaceus development following COVID-19 infection and vaccination: Matched case-control study.
    Arduino PG; Kubanov AA; Vlasova AV; Martynov AA; Svishchenko SI; Petti S
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):e374-e376. PubMed ID: 38217309
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees.
    Jacobson MA; Zakaria A; Maung Z; Hart C; McCalmont TH; Fassett M; Amerson E
    Clin Infect Dis; 2022 Mar; 74(4):591-596. PubMed ID: 34086881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pleuropericardial effusion and systemic inflammatory syndrome secondary to the administration of the mRNA-1273 vaccine for SARS-CoV-2].
    Boira I; Torba A; Castelló C; Esteban V; Vañes S; Chiner E
    Arch Bronconeumol; 2022 Apr; 58(4):372-373. PubMed ID: 35017783
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
    Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC
    J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.
    Solimani F; Mansour Y; Didona D; Dilling A; Ghoreschi K; Meier K
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e649-e651. PubMed ID: 34169588
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
    Izikson R; Brune D; Bolduc JS; Bourron P; Fournier M; Moore TM; Pandey A; Perez L; Sater N; Shrestha A; Wague S; Samson SI
    Lancet Respir Med; 2022 Apr; 10(4):392-402. PubMed ID: 35114141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 31. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
    Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M
    Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1?
    Vuilleumier N; Pagano S; Ludewig B; Schmiedeberg K; Haller C; von Kempis J; Rubbert-Roth A
    Eur J Clin Invest; 2022 Feb; 52(2):e13713. PubMed ID: 34841527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
    Anderson EJ; Rouphael NG; Widge AT; Jackson LA; Roberts PC; Makhene M; Chappell JD; Denison MR; Stevens LJ; Pruijssers AJ; McDermott AB; Flach B; Lin BC; Doria-Rose NA; O'Dell S; Schmidt SD; Corbett KS; Swanson PA; Padilla M; Neuzil KM; Bennett H; Leav B; Makowski M; Albert J; Cross K; Edara VV; Floyd K; Suthar MS; Martinez DR; Baric R; Buchanan W; Luke CJ; Phadke VK; Rostad CA; Ledgerwood JE; Graham BS; Beigel JH;
    N Engl J Med; 2020 Dec; 383(25):2427-2438. PubMed ID: 32991794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemphigus vulgaris following second dose of mRNA-(Pfizer-BioNTech) COVID-19 vaccine.
    Agharbi FZ; Basri G; Chiheb S
    Dermatol Ther; 2022 Oct; 35(10):e15769. PubMed ID: 35960438
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Ogata AF; Cheng CA; Desjardins M; Senussi Y; Sherman AC; Powell M; Novack L; Von S; Li X; Baden LR; Walt DR
    Clin Infect Dis; 2022 Mar; 74(4):715-718. PubMed ID: 34015087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 updates: Moderna COVID-19 vaccine (Spikevax) gains full licensure.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):32. PubMed ID: 35175715
    [No Abstract]   [Full Text] [Related]  

  • 37. A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients.
    Benotmane I; Bruel T; Planas D; Fafi-Kremer S; Schwartz O; Caillard S
    Kidney Int; 2022 May; 101(5):1073-1076. PubMed ID: 35231463
    [No Abstract]   [Full Text] [Related]  

  • 38. Intractable pemphigus foliaceus after COVID-19 mRNA vaccination.
    Matsumoto C; Terada N; Harada Y; Takahashi M; Niiyama S; Fukuda H
    J Dermatol; 2024 Jul; 51(7):e233-e234. PubMed ID: 38321618
    [No Abstract]   [Full Text] [Related]  

  • 39. A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.
    Masuda T; Murakami K; Sugiura K; Sakui S; Philip Schuring R; Mori M
    Vaccine; 2022 Mar; 40(13):2044-2052. PubMed ID: 35177302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A.
    Nakajima Y; Ogiwara K; Shimonishi N; Furukawa S; Takeyama M; Nogami K
    Haemophilia; 2023 May; 29(3):935-938. PubMed ID: 37040322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.